Charité Universitätsmedizin Berlin, Tumorimmunologie Campus Virchow-Klinikum

Berlin 13353

0 studies enrolling now · 1 studies all time

What they study most

Acute GVHD, Acute-graft-versus-host Disease, GVHD, Graft Versus Host Disease, aGVHD

Studies at this site

• A Study of Itolizumab in Combination With Corticosteroids for the First-Line Treatment of Acute Graft Versus Host Disease (EQUATOR) — Stopped early